RNXT ▲ +3.2% - RenovoRx, Inc. $RNXT - RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer 01-OCT-2026 08:30 AM ET